Lamb Weston (LW) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
10 Jan, 2026Executive summary
CEO Tom Werner will step down, succeeded by COO Mike Smith in January 2025, as part of a planned leadership transition.
Q2 FY25 results fell below expectations, with net sales down 8% and a net loss of $36 million due to a $159 million pre-tax restructuring charge.
Adjusted EBITDA declined 25% to $282 million, driven by weak restaurant traffic, increased competition, and higher manufacturing costs.
The company launched a restructuring plan including facility closures, production curtailment, and workforce reductions, targeting $55 million in FY25 pre-tax cost savings.
Persistent industry overcapacity and soft global demand are expected to continue impacting performance.
Financial highlights
Q2 FY25 net sales declined 8% year-over-year to $1,600.9 million; first half net sales down 4% to $3,255.0 million.
Adjusted EBITDA for Q2 was $281.9 million, down $95 million or 25% year-over-year; first half Adjusted EBITDA was $571.8 million, down $217.9 million.
Net loss for Q2 was $36.1 million, compared to net income of $215.0 million in the prior year.
Adjusted SG&A decreased by $12 million to $165 million, reflecting expense reduction initiatives.
Interest expense, net, increased to $43.3 million in Q2, reflecting higher debt levels.
Outlook and guidance
FY25 net sales target reduced to $6.35–$6.45 billion (previously $6.6–$6.8 billion), with adjusted EBITDA guidance lowered to $1.17–$1.21 billion (previously ~$1.38 billion).
Adjusted net income forecast at $440–$460 million; adjusted diluted EPS at $3.05–$3.20 (previously $4.15–$4.35).
Second half sales expected at $3.1–$3.2 billion, with 1–4% growth over prior year period.
EBITDA margin expected at 19–20% in the near to medium term.
Capital expenditures for FY25 set at $750 million, declining to $550 million in FY26.
Latest events from Lamb Weston
- Q3 FY25 sales up 4% with higher volume, cost savings, and reaffirmed guidance amid headwinds.LW
Q3 20254 Feb 2026 - Q4 sales rose 4% with cost savings; 2026 outlook focuses on efficiency and cash flow.LW
Q4 20254 Feb 2026 - Q4 profit plunged on soft demand, share losses, and product withdrawal; FY25 outlook cautious.LW
Q4 20243 Feb 2026 - Net income fell 46% as restructuring and cost actions target $55M in FY25 savings.LW
Q1 202519 Jan 2026 - Q2 2026 saw 8% volume growth, margin headwinds, and a 3% dividend increase.LW
Q2 202619 Dec 2025 - Board refresh, CEO transition, and pay-for-performance drive strategic and governance changes.LW
Proxy Filing1 Dec 2025 - Board recommends approval of all proposals, highlighting governance, pay, and ESG focus.LW
Proxy Filing1 Dec 2025 - Proxy covers director elections, say-on-pay, auditor ratification, and officer exculpation amendment.LW
Proxy Filing1 Dec 2025 - Key votes include director elections, executive pay, auditor ratification, and officer exculpation.LW
Proxy Filing1 Dec 2025